Qiagen NV (NYSE: QGEN) has a higher price-to-earnings ratio of 110.06x compared to its average ratio. QGEN has 36-month beta value of 0.37. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 5 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for QGEN is 221.23M, and currently, short sellers hold a 1.68% ratio of that float. The average trading volume of QGEN on December 19, 2024 was 983.63K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
QGEN) stock’s latest price update
The stock of Qiagen NV (NYSE: QGEN) has increased by 0.87 when compared to last closing price of 44.05.Despite this, the company has seen a loss of -3.32% in its stock price over the last five trading days. zacks.com reported 2024-12-13 that The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here’s why you should take advantage.
QGEN’s Market Performance
Qiagen NV (QGEN) has seen a -3.32% fall in stock performance for the week, with a 8.90% gain in the past month and a -1.04% plunge in the past quarter. The volatility ratio for the week is 1.78%, and the volatility levels for the past 30 days are at 1.63% for QGEN. The simple moving average for the past 20 days is 0.59% for QGEN’s stock, with a 2.17% simple moving average for the past 200 days.
Analysts’ Opinion of QGEN
Many brokerage firms have already submitted their reports for QGEN stocks, with Jefferies repeating the rating for QGEN by listing it as a “Buy.” The predicted price for QGEN in the upcoming period, according to Jefferies is $54 based on the research report published on December 10, 2024 of the current year 2024.
HSBC Securities, on the other hand, stated in their research note that they expect to see QGEN reach a price target of $49. The rating they have provided for QGEN stocks is “Hold” according to the report published on October 17th, 2024.
Wolfe Research gave a rating of “Outperform” to QGEN, setting the target price at $50 in the report published on June 27th of the current year.
QGEN Trading at 2.63% from the 50-Day Moving Average
After a stumble in the market that brought QGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.34% of loss for the given period.
Volatility was left at 1.63%, however, over the last 30 days, the volatility rate increased by 1.78%, as shares surge +5.68% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.07% upper at present.
During the last 5 trading sessions, QGEN fell by -3.22%, which changed the moving average for the period of 200-days by +1.11% in comparison to the 20-day moving average, which settled at $44.17. In addition, Qiagen NV saw 2.32% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at QGEN starting from Sackers Roland, who proposed sale 25,000 shares at the price of $46.00 back on Sep 11 ’24. After this action, Sackers Roland now owns shares of Qiagen NV, valued at $1,150,000 using the latest closing price.
Stock Fundamentals for QGEN
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.5 for the gross margin
The net margin for Qiagen NV stands at 0.05. The total capital return value is set at 0.02. Equity return is now at value 2.57, with 1.53 for asset returns.
Based on Qiagen NV (QGEN), the company’s capital structure generated 0.35 points at debt to capital in total, while cash flow to debt ratio is standing at 0.33. The debt to equity ratio resting at 0.54. The interest coverage ratio of the stock is 2.58.
Currently, EBITDA for the company is 688.55 million with net debt to EBITDA at 2.67. When we switch over and look at the enterprise to sales, we see a ratio of 5.49. The receivables turnover for the company is 5.69for trailing twelve months and the total asset turnover is 0.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.17.
Conclusion
To put it simply, Qiagen NV (QGEN) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
